Armata Pharmaceuticals
ARMP
23 hedge funds and large institutions have $2.06M invested in Armata Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 5 closing their positions.
29% more capital invested
Capital invested by funds: $1.6M → $2.06M (+$462K)
0.16% less ownership
Funds ownership: 3.57% → 3.42% (-0.16%)
8% less funds holding
Funds holding: 25 → 23 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$31.5K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.1K |
| 3 |
BlackRock
New York
|
+$1.9K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$465 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$25.7K |
| 2 |
Jane Street
New York
|
-$24.8K |
| 3 |
Renaissance Technologies
New York
|
-$24.4K |
| 4 |
Goldman Sachs
New York
|
-$17.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$15.1K |
ARMP Hedge Fund Activity: Q1 2023 in Review
23 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Armata Pharmaceuticals (ARMP) for Q1 2023, worth a combined $2.06M — up 29% from $1.6M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ARMP and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 2 added.
The largest buyer was CAPTRUST Financial Advisors, opening a new position worth an estimated $31.5K. The largest seller was HRT Financial, cutting an estimated $25.7K.
- 23 institutional investors held Armata Pharmaceuticals (ARMP) as of Q1 2023, down from 25 in Q4 2022.
- Funds reported $2.06M of Armata Pharmaceuticals stock for Q1 2023, up 29% quarter-over-quarter.
- 3 funds opened new Armata Pharmaceuticals positions in Q1 2023 and 5 closed out, a net change of -2 holders.
- The largest Armata Pharmaceuticals buyer in Q1 2023 was CAPTRUST Financial Advisors, an estimated $31.5K added.
- The largest Armata Pharmaceuticals seller in Q1 2023 was HRT Financial, an estimated $25.7K sold.
Based on aggregated 13F filings for Q1 2023.